In this interview, David Taggart, ART Trial Principal Investigator, critically evaluates the pros and cons of the trial and its key takeaways.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
September 3, 2019
Remote ischemic preconditioning did not influence 12-month survival or readmission rates in a randomized trial involving more than 5,400 patients undergoing percutaneous coronary intervention after ST-segment elevation MI.
September 2, 2019
The authors reviewed the New York State database. Patients with single arterial grafts were compared to those with multiple arterial grafts. Propensity matching was performed based on 38 baseline characteristics. Twenty percent had multiple arterial grafting.
September 1, 2019
Interesting viewpoint of a cardiologist on low-SYNTAX subjects.
August 31, 2019
The growth and replication of cardiomyocytes derived from stem cells is insufficient to permit regeneration of functioning heart tissue. In this study, the authors used stem cell-derived epicardial cells to facilitate myocardial regeneration.
August 31, 2019
This review details the risks of surgical smoke exposure, which include lung injury and cancer. The level of risk has yet to be determined. Most operating rooms do not require smoke evacuation devices, but their use should be considered.
August 30, 2019
In this best evidence topic paper, the authors examined outcome and safety of innominate artery cannulation versus axillary artery cannulation in thoracic aortic surgery. There were no significant differences in mortality with innominate artery cannulation compared to axillary artery cannulation.
August 30, 2019
Gershengorn and colleagues evaluated the incidence and safety of overnight extubation following coronary artery bypass grafting (CABG), using retrospective data from The Society of Thoracic Surgeons Adult Cardiac Surgery Database.
August 29, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, USA, Jill Ley of California Pacific Medical Center in San Francisco moderates a discussion on the ERAS multidisciplinary team.
August 29, 2019
Using an approach that minimizes valve depth relative to the membranous septum, the authors reduced the need for permanent pacemaker placement to a reliable and predictable 3% compared to the accepted standard of 10%.